Beijing Tong Ren Tang Chinese Medicine Company Limited

SEHK:3613 Stok Raporu

Piyasa değeri: HK$6.9b

Beijing Tong Ren Tang Chinese Medicine Gelecekteki Büyüme

Future kriter kontrolleri 3/6

Beijing Tong Ren Tang Chinese Medicine kazanç ve gelirin sırasıyla yıllık 16.5% ve 14.8% oranında artacağı tahmin edilmektedir. EPS'nin yıllık 16.5% oranında büyümesi beklenmektedir. Özkaynak kârlılığının 3 yıl içinde 15.7% olacağı tahmin edilmektedir.

Anahtar bilgiler

16.5%

Kazanç büyüme oranı

16.5%

EPS büyüme oranı

Pharmaceuticals kazanç büyümesi11.0%
Gelir büyüme oranı14.8%
Gelecekteki özkaynak getirisi15.7%
Analist kapsamı

Low

Son güncelleme11 Sep 2024

Gelecekteki son büyüme güncellemeleri

Recent updates

Beijing Tong Ren Tang Chinese Medicine Company Limited's (HKG:3613) Shares Climb 32% But Its Business Is Yet to Catch Up

Oct 04
Beijing Tong Ren Tang Chinese Medicine Company Limited's (HKG:3613) Shares Climb 32% But Its Business Is Yet to Catch Up

Earnings Troubles May Signal Larger Issues for Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Shareholders

Sep 06
Earnings Troubles May Signal Larger Issues for Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Shareholders

Is There An Opportunity With Beijing Tong Ren Tang Chinese Medicine Company Limited's (HKG:3613) 31% Undervaluation?

Sep 02
Is There An Opportunity With Beijing Tong Ren Tang Chinese Medicine Company Limited's (HKG:3613) 31% Undervaluation?

Beijing Tong Ren Tang Chinese Medicine Company Limited's (HKG:3613) 28% Share Price Plunge Could Signal Some Risk

Feb 05
Beijing Tong Ren Tang Chinese Medicine Company Limited's (HKG:3613) 28% Share Price Plunge Could Signal Some Risk

Calculating The Intrinsic Value Of Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613)

Jan 03
Calculating The Intrinsic Value Of Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613)

A Look At The Intrinsic Value Of Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613)

Sep 28
A Look At The Intrinsic Value Of Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613)

Here's Why We Think Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Might Deserve Your Attention Today

Jul 12
Here's Why We Think Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Might Deserve Your Attention Today

Is Now The Time To Put Beijing Tong Ren Tang Chinese Medicine (HKG:3613) On Your Watchlist?

Mar 29
Is Now The Time To Put Beijing Tong Ren Tang Chinese Medicine (HKG:3613) On Your Watchlist?

Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Has Announced That It Will Be Increasing Its Dividend To HK$0.28

Apr 28
Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Has Announced That It Will Be Increasing Its Dividend To HK$0.28

Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Will Pay A Larger Dividend Than Last Year At HK$0.28

Mar 25
Beijing Tong Ren Tang Chinese Medicine (HKG:3613) Will Pay A Larger Dividend Than Last Year At HK$0.28

Are Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Investors Paying Above The Intrinsic Value?

Oct 27
Are Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Investors Paying Above The Intrinsic Value?

Beijing Tong Ren Tang Chinese Medicine's (HKG:3613) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Apr 28
Beijing Tong Ren Tang Chinese Medicine's (HKG:3613) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Read This Before Selling Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Shares

Mar 11
Read This Before Selling Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Shares

What Type Of Returns Would Beijing Tong Ren Tang Chinese Medicine's(HKG:3613) Shareholders Have Earned If They Purchased Their SharesYear Ago?

Feb 04
What Type Of Returns Would Beijing Tong Ren Tang Chinese Medicine's(HKG:3613) Shareholders Have Earned If They Purchased Their SharesYear Ago?

Should Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Be Part Of Your Dividend Portfolio?

Jan 18
Should Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Be Part Of Your Dividend Portfolio?

Could The Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Ownership Structure Tell Us Something Useful?

Dec 29
Could The Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Ownership Structure Tell Us Something Useful?

Read This Before Selling Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Shares

Dec 11
Read This Before Selling Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613) Shares

Beijing Tong Ren Tang Chinese Medicine Company Limited's (HKG:3613) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Nov 23
Beijing Tong Ren Tang Chinese Medicine Company Limited's (HKG:3613) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Kazanç ve Gelir Büyüme Tahminleri

SEHK:3613 - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (HKD Millions )
TarihGelirKazançlarSerbest Nakit AkışıFaaliyetlerden NakitAvg. Analist Sayısı
12/31/20262,011738N/AN/A1
12/31/20251,850671N/A6572
12/31/20241,628559N/A6812
6/30/20241,377494-384-358N/A
3/31/20241,4515172852N/A
12/31/20231,525540439461N/A
9/30/20231,721619552584N/A
6/30/20231,918697665706N/A
3/31/20231,824672587627N/A
12/31/20221,731646509547N/A
9/30/20221,605601636665N/A
6/30/20221,478555763782N/A
3/31/20221,517582758779N/A
12/31/20211,556608754777N/A
9/30/20211,504595575596N/A
6/30/20211,452583397414N/A
3/31/20211,384563250265N/A
12/31/20201,315542103116N/A
9/30/20201,246483198213N/A
6/30/20201,178424294310N/A
3/31/20201,305490414430N/A
12/31/20191,433556534551N/A
9/30/20191,505594553568N/A
6/30/20191,577632572585N/A
3/31/20191,546601N/AN/AN/A
12/31/20181,514581524578N/A
9/30/20181,466552N/AN/AN/A
6/30/20181,402540447507N/A
3/31/20181,330516N/AN/AN/A
12/31/20171,266490N/A469N/A
9/30/20171,212469N/AN/AN/A
6/30/20171,166449N/A465N/A
3/31/20171,134444N/AN/AN/A
12/31/20161,084420N/A468N/A
9/30/20161,063431N/AN/AN/A
6/30/20161,028410N/A415N/A
3/31/20161,002380N/AN/AN/A
12/31/2015970354N/A354N/A
9/30/2015939337N/AN/AN/A
6/30/2015881320N/A316N/A
3/31/2015834304N/AN/AN/A
12/31/2014761287N/A245N/A
9/30/2014733286N/AN/AN/A
6/30/2014699267N/A202N/A
3/31/2014652249N/AN/AN/A
12/31/2013614220N/A143N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: 3613 'nin tahmini kazanç büyümesi (yıllık 16.5% ) tasarruf oranının ( 2.3% ) üzerindedir.

Kazançlar ve Piyasa: 3613 şirketinin kazançlarının (yıllık 16.5% ) Hong Kong pazarından (yıllık 11.6% ) daha hızlı büyümesi öngörülüyor.

Yüksek Büyüme Kazançları: 3613 şirketinin kazançlarının artması bekleniyor, ancak önemli ölçüde.

Gelir ve Pazar: 3613 şirketinin gelirinin (yıllık 14.8% ) Hong Kong pazarından (yıllık 7.8% ) daha hızlı büyümesi öngörülüyor.

Yüksek Büyüme Geliri: 3613 şirketinin gelirinin (yıllık 14.8% ) yıllık 20% oranından daha yavaş büyümesi öngörülüyor.


Hisse Başına Kazanç Büyüme Tahminleri


Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: 3613 'nin Özsermaye Getirisi'nin 3 yıl içinde düşük olması tahmin ediliyor ( 15.7 %).


Büyüyen şirketleri keşfedin